Resources about inherited cancer risk for healthcare providers
Approximately 5-10% of all cancer is due to hereditary cancer syndromes. More cancers are likely influenced by genetic factors associated with moderate risk. Being able to identify individuals at increased cancer risk through family history and, in some cases, genetic testing, can influence management and outcomes through increasing screening and/or risk-reducing interventions. The resources below provide opportunities to learn about hereditary cancer syndromes, identify individuals at increased risk, interpret genetic testing results, apply genetic information to management, collaborate with genetics professionals, and communicate with patients. We also have resources about somatic testing and targeted therapies, which are available on our Precision Oncology Resources page.
These factsheets describe the clinical features, diagnosis, testing, and genetics of the following hereditary cancer syndromes.
Family History Collection Tips & Tools. Provides tips, resources, and tools for family history collection in clinical practice.
Cancer Genetic Risk Assessment. Helps identify red flags and stratify cancer risk based on family history.
Genetically Related Cancers. Provides key features and cancer risks associated with common hereditary cancer syndromes.
Risk Assessment and Screening Toolkit to Detect Familial, Hereditary, and Early Onset Colorectal Cancer. Helps primary care providers implement a structured family history collection system to identify and manage individuals at increased or high risk of colorectal cancer (CRC), and to facilitate timely diagnostic evaluation of patients with signs or symptoms of early onset CRC.
Comparing Genetic Tests. Provides a quick reference for the detection capabilities for common types of genetic testing, such as gene sequencing and deletion/duplication analysis.
Genetic Testing Methods eBook. Provides information about different genetic testing methods currently used in testing for hereditary cancer syndromes (enhanced e-book available for download).
Genetic Testing Results Interpretation Tool. Outlines how to interpret results from cancer genetic testing in different patient situations.
Cancer Screening. Summarizes professional society guidance about screening for individuals at average, increased, and high risk for breast, prostate, and colorectal cancer.
Hereditary Cancer Management Guidelines. Provides access to current management guidelines based on genetic or familial risk.
Communicating Genetic Risk. Outlines key points to consider when communicating risk to patients.
Pretest Counseling Recommendations. Outlines key points to address during pretest counseling.
Informed Consents and Pretest Counseling Checklist. Provides a checklist of key points to cover with patients prior to genetic testing.
Communicating with Family. Outlines key points to consider when discussing family communication with patients.
Components of a Cancer Genetic Counseling Session. Discusses the core components of a cancer genetic counseling session.
Accessing Genetic Services. Lists tools and websites to help find genetics professionals and provides patient talking points about referring to genetics. Find cancer genetic services in ME, CT, and Western NY.
Hereditary Breast Cancer Patient and Family Resources. Provides patient resources for understanding genetic services and breast cancer genetics.
Beyond Genetics: Genomics in Breast Cancer Diagnosis, Treatment, and Research. Explores one cancer survivor’s journey through diagnosis, treatment, and life after treatment.
Free, self-directed programs for continuing education credit.
Cancer Genetic Clinical Education Program
Build skills to identify and manage patients who at increased risk of cancer based on family health history and/or genetic testing. Choose from 11 short, case-based modules.
Hereditary Cancer Syndromes: Are Your Patients at Risk?
Develop skills and knowledge to identify patients with cancer who are most appropriate for germline testing, choose the right test, and using the results to develop a management plan.
Access CME Module
A JAX team developed CUP-AI-Dx, a machine learning tool that uses RNA sequence data for analysis. The researchers show that...
JAX researchers report in Cancer Cell further insight into yet another way extrachromosomal, circular DNA (ecDNA) may...
In the hunt for genetic cancer risk factors, researchers painstakingly analyze huge amounts of genome sequence data.
PDX models provide researchers with the ability to work with tumors directly from patients within a living (in vivo) system, making them a...
I study the implication of myeloid cells, particularly antigen-presenting cells (APCs), in antiviral immune response.
Computational Oncology studies that integrate clinical, genomic, and imaging data to explore the dynamics of tumor heterogeneity and...
New research done by a JAX researcher suggests that certain cells can act as a biomarker for metastatic melanoma as well as...
Onco-Hu® models are a robust immuno-oncology platform for efficacy testing of novel immunotherapies targeting T cells and myeloid cells to...
Cutting Edge Bioinformatics for Preclinical Oncology. Dig deeper to understand tumor response or resistance to your...
Online Resources for Cancer Research
There are hundreds of JAX® Mice strains available for cancer research and drug efficacy testing. The table below summarizes...
Cutting edge sequencing for preclinical oncology.
Patient-derived tumor xenografts in humanized NSG™ and NSG™-SGM3 mice
The JAX ActionSeq™ test is a targeted panel of 212 cancer related genes analyzed using next-generation sequencing. The panel assesses all...
Allow essential cookies
Required for basic site operations.
Allow analytics cookies
Used to analyze web traffic to improve the user experience.
Allow marketing cookies
Used to deliver personalized information and tailor communications.